Clinical Indication ID & Name
Inherited phaeochromocytoma and paraganglioma excluding NF1
Test Group
Endocrinology
Specialties
Test code
R223.1
Test name
N/A
Target genes
Inherited phaeochromocytoma and paraganglioma excluding NF1 (649)
Test scope
n/a
Test method/ technology
Small panel
Optimal Family Structure
n/a
Eligibility Criteria
Testing of individual (proband) affected with cancer where the individual +/- family history meets one of the
following criteria. The proband has:
1. Phaeochromocytoma <60 years, OR
2. Any paraganglioma OR metastatic phaeochromocytoma at any age, OR
3. Phaeochromocytoma / paraganglioma with loss of staining for SDH proteins on IHC, OR
4. Bilateral phaeochromocytoma (any age), OR
5. Phaeochromocytoma and renal cell carcinoma (any age), OR
6. Phaeochromocytoma / paraganglioma (any age) AND ≥1 relative (first / second / third degree relative)
with phaeochromocytoma / paraganglioma / renal cell cancer (any age) / gastrointestinal stromal tumour
NOTE: The proband's cancer and majority of reported cancers in the family should have been confirmed
NOTE: Testing under this clinical indication does not include NF1
Test code
R223.2
Test name
N/A
Target genes
SDHB;SDHC;SDHD
Test scope
n/a
Test method/ technology
MLPA or equivalent
Optimal Family Structure
n/a
Eligibility Criteria
Testing of individual (proband) affected with cancer where the individual +/- family history meets one of the
following criteria. The proband has:
1. Phaeochromocytoma <60 years, OR
2. Any paraganglioma OR metastatic phaeochromocytoma at any age, OR
3. Phaeochromocytoma / paraganglioma with loss of staining for SDH proteins on IHC, OR
4. Bilateral phaeochromocytoma (any age), OR
5. Phaeochromocytoma and renal cell carcinoma (any age), OR
6. Phaeochromocytoma / paraganglioma (any age) AND ≥1 relative (first / second / third degree relative)
with phaeochromocytoma / paraganglioma / renal cell cancer (any age) / gastrointestinal stromal tumour
NOTE: The proband's cancer and majority of reported cancers in the family should have been confirmed
NOTE: Testing under this clinical indication does not include NF1
Commissioning group
Specialised
Overlapping idications
• R363 Inherited predisposition to GIST should be used where GIST is a prominent cancer type in the family • M13 Phaeochromocytoma should be used for somatic testing
Address for samples/request forms
Please refer to the test request form.
Contact with queries
Supporting documents
n/a
Education resources
n/a
Service updates
n/a
Request form download
Form not available, please contact us to enquire.
Consent record
See consent guidance in test request form
Sample requirements
Sample Requirements Each sample must be sent labelled with 3 patient identifiers and must state the sample type clearly on the sample container. Sample Rejection Samples may be rejected for the following reasons: 1. Samples and request form do not show at least three identical patient identifiers 2. The sample is in the incorrect collection media 3. The request form is not sufficiently completed 4. The sample is not of sufficient volume 5. The sample is too old Sample Storage and Volume Required: Perirpheral blood in an EDTA tube: Adult and children 4 ml, Infants (0-2 years) 1 ml or a DNA sample (3-5µg of purified DNA). Where it is not possible to collect peripheral blood we will accept a saliva sample (please contact the lab for specific details). Storage, sample packing and transportation: Blood should be stored at 4°C where possible. Send at room temperature by first class post or by courier. Patient/Clinician Instructions: N/A Factors affecting performance of test/interpretation of results: Clotted samples are unsuitable for DNA analysis. Blood Samples in incorrect anticoagulant tubes may be rejected.